BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 15060972)

  • 1. [Preventing of postmenopausal osteoporosis by hormone replacement therapy? Is the risk acceptable?].
    Wirthner D; Cornuz J; Lamy O
    Praxis (Bern 1994); 2004 Feb; 93(9):315-20. PubMed ID: 15060972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hormone replacement therapy and the risk of developing breast cancer].
    Merz WE
    MMW Fortschr Med; 2004 Feb; 146(9):26-8, 30. PubMed ID: 15352702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hormone replacement therapy: curse or blessing?].
    Schmidt M; Fink D; Lang U; Kimmig R
    Gynakol Geburtshilfliche Rundsch; 2006; 46(4):165. PubMed ID: 17068400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postmenopausal hormone replacement therapy: does the progestin make a difference?
    Fylstra DL
    J S C Med Assoc; 2002 Feb; 98(1):12-9. PubMed ID: 11859600
    [No Abstract]   [Full Text] [Related]  

  • 5. [The benefits and risks of hormonal replacement therapy--an update].
    Schmidt M; Kimmig R
    Gynakol Geburtshilfliche Rundsch; 2006; 46(4):166-73. PubMed ID: 17068401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormone replacement therapy in the post-Women's Health Initiative era. Report a a meeting held in Funchal, Madeira, February 24-25, 2003.
    Burger H
    Climacteric; 2003 May; 6 Suppl 1():11-36. PubMed ID: 12945798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hormone replacement therapy in peri- and postmenopause. Routine use is not indicated].
    Emons G; Westphalen S
    MMW Fortschr Med; 2002 Feb; 144(9):30-3. PubMed ID: 11921648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormone replacement therapy in postmenopausal women.
    Yasui T; Uemura H; Takikawa M; Irahara M
    J Med Invest; 2003 Aug; 50(3-4):136-45. PubMed ID: 13678382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 10-year follow-up of postmenopausal women on long-term continuous combined hormone replacement therapy: Update of safety and quality-of-life findings.
    Heikkinen J; Vaheri R; Timonen U
    J Br Menopause Soc; 2006 Sep; 12(3):115-25. PubMed ID: 16953985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health risks outweigh benefits for combined estrogen plus progestin. Clinical trial stopped early in major study.
    American Medical Association
    Ginecol Obstet Mex; 2002 Aug; 70():411-2. PubMed ID: 12449905
    [No Abstract]   [Full Text] [Related]  

  • 11. [After the early termination of the Women's Health Initiative study. New American recommendations for postmenopausal hormone therapy].
    Stjernquist M;
    Lakartidningen; 2003 May; 100(20):1790-7. PubMed ID: 12806859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current issues in hormone replacement therapy.
    Timins JK
    N J Med; 2004 Mar; 101(3):21-7. PubMed ID: 15042800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormone replacement therapy and cancer.
    Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Some problems of postmenopausal osteoporosis prevention with hormone replacement therapy].
    Liu JL
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Jun; 25(3):240-3. PubMed ID: 12905731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New evidence regarding hormone replacement therapies is urgently required transdermal postmenopausal hormone therapy differs from oral hormone therapy in risks and benefits.
    Modena MG; Sismondi P; Mueck AO; Kuttenn F; Lignières Bd; Verhaeghe J; Foidart JM; Caufriez A; Genazzani AR;
    Maturitas; 2005 Sep; 52(1):1-10. PubMed ID: 15963666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of medroxyprogesterone acetate on estrogen-dependent risks and benefits--an attempt to interpret the Women's Health Initiative results.
    Kuhl H; Stevenson J
    Gynecol Endocrinol; 2006 Jun; 22(6):303-17. PubMed ID: 16785155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of the Women's Health Initiative on hormone replacement therapy in a Medicaid program.
    Hillman JJ; Zuckerman IH; Lee E
    J Womens Health (Larchmt); 2004 Nov; 13(9):986-92. PubMed ID: 15665655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Where are we with postmenopausal hormone therapy in 2005?
    Lam PM; Chung TK; Haines C
    Gynecol Endocrinol; 2005 Nov; 21(5):248-56. PubMed ID: 16373243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HRT: forever or never?
    Corson SL
    Int J Fertil Womens Med; 2002; 47(4):150-1. PubMed ID: 12199410
    [No Abstract]   [Full Text] [Related]  

  • 20. National Osteoporosis Society's Position statement on hormone replacement therapy in the prevention and treatment of osteoporosis.
    Bowring CE; Francis RM
    Menopause Int; 2011 Jun; 17(2):63-5. PubMed ID: 21693502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.